TG Therapeutics, Inc

(NASDAQ:TGTX)

Latest On TG Therapeutics, Inc (TGTX):

Date/Time Type Description Signal Details
2023-05-06 07:44 ESTNewsTG Therapeutics' Stock Surge: Exploring The Factors And Exercising Caution (Rating Upgrade)N/A
2023-05-02 02:37 ESTNewsTG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update)N/A
2023-05-01 14:23 ESTNewsTG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42MN/A
2023-05-01 14:23 ESTNewsTG Therapeutics slips despite Q1 beatN/A
2023-05-01 14:22 ESTNewsTG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call TranscriptN/A
2023-04-29 00:22 ESTNewsTG Therapeutics: A Plethora Of Good News, Strong Revenues ExpectedN/A
2023-04-27 23:34 ESTNewsTG Therapeutics gains after reimbursement win for multiple sclerosis therapyN/A
2023-04-11 19:18 ESTNewsTG Therapeutics extends rally to hit 52-week high after B. Riley commentsN/A
2023-04-11 19:18 ESTNewsHot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA fallsN/A
2023-04-11 04:01 ESTNewsTG Therapeutics jumps 22% as Cantor cites strong Briumvi salesN/A
2023-03-31 11:03 ESTNewsTG Therapeutics' multiple sclerosis drug Briumvi gets EMA panel backingN/A
2023-03-22 17:59 ESTNewsTG Therapeutics' Briumvi Has Potential For Growth In A Crowded MarketN/A
2023-03-20 19:43 ESTNewsTG Therapeutics: That ICER Report Doesn't Bother MeN/A
2023-03-09 23:16 ESTNewsTG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICERN/A
2023-03-01 01:53 ESTNewsTG Therapeutics, Inc. (TGTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 10:24 ESTNewsTG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52MN/A
2023-02-27 20:17 ESTNewsTG Therapeutics Q4 2022 Earnings PreviewN/A
2023-02-23 20:12 ESTNewsTG Therapeutics' Briumvi: A Tough Sell For Multiple Sclerosis Treatment MarketN/A
2023-02-07 11:09 ESTNewsTG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapyN/A
2023-02-01 21:47 ESTNewsTG Therapeutics: Strategy After Briumvi LaunchN/A
2023-01-26 12:41 ESTNewsTG Therapeutics launches newly approved multiple sclerosis therapyN/A
2023-01-11 14:59 ESTNewsTG Therapeutics adds 10% to extend gains after insider purchaseN/A
2023-01-02 17:51 ESTNewsTG Therapeutics: Ramifications Of Briumvi ApprovalN/A
2022-12-29 23:50 ESTNewsTG Therapeutics surges as focus turns to launch of new multiple sclerosis therapyN/A
2022-12-28 18:27 ESTNewsTG Therapeutics jumps 19% as FDA approves multiple sclerosis therapyN/A
2022-12-24 22:09 ESTNewsStocks To Watch: Nio, Tesla And Hopes For A Santa Clause RallyN/A
2022-12-17 21:07 ESTNewsIt's almost 2023, but here are the drugs the FDA could approve before the end of the yearN/A
2022-12-15 16:42 ESTNewsTG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024N/A
2022-12-14 23:31 ESTNewsTG Therapeutics: Would Santa Deliver An Early Present?N/A
2022-11-13 05:29 ESTNewsTG Therapeutics (TGTX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 23:59 ESTNewsTG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61MN/A
2022-11-10 23:59 ESTNewsTG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapyN/A
2022-10-09 13:35 ESTNewsTG Therapeutics: Elucidating The Upcoming BinaryN/A
2022-09-21 15:15 ESTNewsTG Therapeutics: We Are Just Hanging In ThereN/A
2022-08-25 19:03 ESTNewsTG Therapeutics announces peer-reviewed publication of multiple sclerosis phase 3 trialsN/A
2022-08-09 08:40 ESTNewsTG Therapeutics stock soars 18% on Q2 beat as net loss narrows; eyes MS drug win by year-endN/A
2022-08-09 08:40 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 09:01 ESTNewsTG Therapeutics GAAP EPS of -$0.30 beats by $0.17, revenue of $0.6M beats by $0.42MN/A
2022-08-06 00:27 ESTNewsTG Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-09 02:04 ESTNewsTG Therapeutics And Ublituximab: From Icing To LifelineN/A
2022-06-01 21:32 ESTNewsTG Therapeutics slips as FDA withdraws approval for cancer drugN/A
2022-05-31 12:26 ESTNewsTG Therapeutics announces delay in FDA review for multiple sclerosis drugN/A
2022-05-21 18:22 ESTNewsTG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drugN/A
2022-04-22 18:32 ESTNewsTG Therapeutics: Can The Company Successfully Turn Around?N/A
2022-04-18 21:06 ESTNewsTG Therapeutics: I May Double Down AgainN/A
2022-04-18 21:06 ESTNewsTG Therapeutics extends losses as H.C. Wainwright slashes target on Ukoniq setbackN/A
2022-04-18 06:43 ESTNewsTG Therapeutics stock falls 24% as it withdraws Ukoniq from sale, pulls filing with FDAN/A
2022-03-03 18:32 ESTNewsTG Therapeutics stock falls as FDA extends review of blood cancer drug comboN/A
2022-03-01 13:48 ESTNewsTG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08MN/A
2022-03-01 13:47 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2021 Results - Earnings Call TranscriptN/A

About TG Therapeutics, Inc (TGTX):

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.

See Advanced Chart

General

  • Name TG Therapeutics, Inc
  • Symbol TGTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 272
  • Last Split Factor100:5625
  • Last Split Date2012-04-30
  • Fiscal Year EndDecember
  • IPO Date1995-12-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.tgtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 36580.51
  • Price/Book (Most Recent Quarter) 13.05
  • Enterprise Value Revenue 40882.96
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.06
  • Next Year EPS Estimate -$0.80
  • Next Quarter EPS Estimate -$0.50
  • Operating Margin -179996%
  • Return on Assets -43%
  • Return on Equity -100%
  • Revenue 152000
  • Earnings Per Share -$1.96
  • Revenue Per Share $0
  • Gross Profit 152000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 6.47 billion
  • EBITDA -158616992
  • PE Ratio 37.85
  • Analyst Target Price $75.33
  • Book Value Per Share $4.00
View More

Share Statistics

  • Shares Outstanding 137.81 million
  • Shares Float 120.36 million
  • % Held by Insiders 713%
  • % Held by Institutions 67.24%
  • Shares Short 11.84 million
  • Shares Short Prior Month 11.76 million
  • Short Ratio 8
  • Short % of Float 10%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 2.13
  • 52 Week High $56.74
  • 52 Week Low $7.12
  • 50 Day Moving Average 46.97
  • 200 Day Moving Average 37.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

TG Therapeutics, Inc (TGTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

TG Therapeutics, Inc (TGTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$38000-$0.72-$0.58-23.78%
2020-09-302020-11-09$N/A-$0.73-$0.41-76.76%
2020-06-302020-08-10$N/A-$0.47-$0.34-39.05%
2020-03-312020-05-11$38000-$0.48-$0.36-34.08%
2019-12-312020-03-02$38000-$0.44-$0.42-5.39%
2019-09-302019-11-12$38000-$0.69-$0.34-104.44%
2019-06-302019-08-09$38000-$0.42-$0.444.55%
2019-03-312019-05-10$38000-$0.43-$0.441.15%
2018-12-312019-03-01$38000-$0.69-$0.44-55.41%
2018-09-302018-11-09$38000-$0.43-$0.5420.37%
2018-06-302018-08-07$38000-$0.59-$0.53-12.38%
2018-03-312018-05-08$38000-$0.59-$0.44-34.09%
2017-12-312018-03-08$38000-$0.46-$0.44-4.14%
2017-09-302017-11-08$38000-$0.48-$0.43-11.63%
2017-06-302017-08-09$38000-$0.45-$0.43-5.26%
2017-03-312017-05-05$38000-$0.52-$0.41-27.45%
2016-12-312017-03-10$38000-$0.48-$0.36-33.33%
2016-09-302016-11-07$38000-$0.50-$0.31-61.29%
2016-06-302016-08-08$38000-$0.33-$0.29-15.79%
2016-03-312016-05-10$38000-$0.28-$0.3621.5%
2015-12-312016-03-07$38000-$0.37-$0.32-16.83%
2015-09-302015-11-09$38000-$0.28-$0.3417.65%
2015-06-302015-08-10$38000-$0.38-$0.30-26.67%
2015-03-312015-05-04$38000-$0.39-$0.33-18.18%
2014-12-312015-03-11$38000-$0.48-$0.26-84.62%
2014-09-302014-11-10$38000-$0.51-$0.32-59.38%
2014-06-302014-07-21$38000-$0.32-$0.24-33.33%
2014-03-312014-05-12$38000-$0.25-$0.18-38.89%
2013-12-312014-03-05$38000-$0.19-$0.17-11.76%
2013-09-302013-11-11$38000-$0.16-$0.2227.27%
2013-06-302013-08-01$38000-$0.29-$0.16-81.25%
2013-03-312013-05-14$38000-$0.17-$0.15-13.33%
2012-12-312013-03-12$19000-$0.12-$0.137.69%
2012-09-302012-11-08$N/A-$0.16-$0.12-33.33%
2012-06-302012-08-09$N/A-$0.16-$0.06-166.67%
2012-03-312012-05-21$N/A-$2.03
2011-09-302011-11-14$N/A-$9.05
2011-06-302011-08-15$N/A-$64.63
2011-03-312011-05-23$N/A$84.58
2010-12-312011-03-02$N/A$9.18
2010-09-302010-11-15$N/A$0.96
2010-06-302010-08-16$N/A$43.21
2010-03-312010-05-24$N/A-$54.27
2009-12-312010-03-03$N/A-$8.88
2009-09-302009-11-16$N/A-$16.57
2009-06-302009-08-14$N/A-$55.45
2009-03-312009-05-19$N/A-$30.34
2008-12-312009-02-25$N/A$5.06
2008-09-302008-12-03$N/A-$55.53
2008-06-302008-08-19$N/A-$56.64
2008-03-312008-05-20$N/A-$62.10
2007-09-302007-11-14$N/A-$112.50-$28.12-300.07%
2007-06-302007-07-09$N/A-$112.50-$84.37-33.34%
2007-03-312007-05-15$N/A-$119.73
2006-09-302006-11-14$N/A-$84.37-$84.370%
2006-06-302006-08-14$N/A-$112.50-$112.500%
2006-03-312006-05-15$N/A-$140.62-$140.620%
2005-09-302005-09-30$N/A-$118.85
2005-06-302005-06-30$N/A-$934.25
2005-03-312005-03-31$N/A-$152.43
2004-12-312004-12-31$N/A-$196.87
2004-09-302004-09-30$N/A-$240.39
2004-06-302004-06-30$N/A-$109.61
2004-03-312004-03-31$N/A-$140.65
2003-12-312003-12-31$N/A-$225.00
2003-09-302003-09-30$N/A-$391.61
2003-06-302003-06-30$N/A-$93.46
2003-03-312003-03-31$N/A-$91.67
2002-09-302002-09-30$N/A-$507.41
2002-06-302002-06-30$N/A$24.21
2002-03-312002-03-31$N/A-$552.10
2001-09-302001-09-30$N/A-$1,528.45
2001-06-302001-06-30$-2712000-$4,513.55
2001-03-312001-03-31$2.71 million$1,855.58
2000-09-302000-09-30$1.07 million-$2,621.34
2000-06-302000-06-30$1.44 million-$7,888.48
2000-03-312000-03-31$925000-$5,766.57
1999-09-301999-09-30-$986.48
1999-06-301999-06-30-$1,929.43
1999-03-311999-03-31-$2,666.06
1998-09-301998-09-30-$5,140.91
1998-06-301998-06-30$695.14
1998-03-311998-03-31-$9,885.89

TG Therapeutics, Inc (TGTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

TG Therapeutics, Inc (TGTX) Chart:

TG Therapeutics, Inc (TGTX) News:

Below you will find a list of latest news for TG Therapeutics, Inc (TGTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

TG Therapeutics, Inc (TGTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-02-201514.1CALL0 34193.03TRUE00
2026-02-201617.18CALL0 1175.49TRUE00
2026-02-201713.7CALL0 1159.02TRUE00
2026-02-20180CALL0 0143.46TRUE00
2026-02-20190CALL0 0147.49TRUE00
2026-02-202010CALL0 3070TRUE00
2026-02-202111.03CALL0 100117.27TRUE00
2026-02-20227.29CALL0 206103.04TRUE00
2026-02-20238.25CALL0 1389.28TRUE00
2026-02-20246.3CALL0 1300TRUE00
2026-02-20253.13CALL0 2180TRUE00
2026-02-20262.58CALL0 700TRUE00
2026-02-20272.5CALL10 23458.93TRUE-0.2-0.07
2026-02-20282CALL0 28446.11TRUE00
2026-02-20291.15CALL26 42439.75TRUE-0.3-0.21
2026-02-20300.56CALL36 119246.94FALSE-0.21-0.27
2026-02-20310.45CALL14 145857.4FALSE-0.05-0.1
2026-02-20320.17CALL19 138250.3FALSE0.010.06
2026-02-20330.1CALL563 172353.23FALSE-0.05-0.33
2026-02-20340.12CALL0 135462.58FALSE00
2026-02-20350.1CALL2 204771.35FALSE00
2026-02-20360.11CALL1 71681.28FALSE0.110
2026-02-20370.1CALL0 392140FALSE00
2026-02-20380.05CALL0 66695.04FALSE00
2026-02-20390.25CALL0 309154.7FALSE00
2026-02-20400.08CALL0 698163.41FALSE00
2026-02-20410.05CALL0 3171.75FALSE00
2026-02-20422.35CALL0 11179.76FALSE00
2026-02-20430.12CALL0 70187.46FALSE00
2026-02-20450.08CALL0 133202.04FALSE00
2026-02-20500.05CALL0 247223.41FALSE00
2026-02-20550.05CALL0 304189.62FALSE00
2026-02-20150.2PUT0 9237.12FALSE00
2026-02-20160.13PUT0 1200.89FALSE00
2026-02-20170.63PUT0 0183.07FALSE00
2026-02-20180.43PUT0 3166.18FALSE00
2026-02-20190.43PUT0 1150.11FALSE00
2026-02-20200.05PUT0 54172.86FALSE00
2026-02-20210PUT0 0119.98FALSE00
2026-02-20220.15PUT0 19115.57FALSE00
2026-02-20230.05PUT0 102100.82FALSE00
2026-02-20240.26PUT0 19186.41FALSE00
2026-02-20250.18PUT0 31268.87FALSE00
2026-02-20260.32PUT0 15581.01FALSE00
2026-02-20270.16PUT1 54644.8FALSE-0.04-0.2
2026-02-20280.45PUT11 68048.66FALSE0.060.15
2026-02-20291.44PUT1 37641.97FALSE0.741.06
2026-02-20301.1PUT0 110641.79TRUE00
2026-02-20311.85PUT4 12127.9TRUE1.850
2026-02-20323PUT0 9744.62TRUE00
2026-02-20332.93PUT0 360TRUE00
2026-02-20345.15PUT0 4240TRUE00
2026-02-20356PUT0 1790TRUE00
2026-02-20367.38PUT0 140TRUE00
2026-02-20375.72PUT0 230TRUE00
2026-02-20386.67PUT0 40TRUE00
2026-02-20397.3PUT0 00TRUE00
2026-02-204010.16PUT0 00TRUE00
2026-02-20418.8PUT0 00TRUE00
2026-02-20420PUT0 00TRUE00
2026-02-20430PUT0 00TRUE00
2026-02-204514.5PUT0 00TRUE00
2026-02-20500PUT0 00TRUE00
2026-02-20550PUT0 00TRUE00
2026-03-20200CALL0 091.71TRUE00
2026-03-20210CALL0 085.52TRUE00
2026-03-20220CALL0 089.78TRUE00
2026-03-20230CALL0 0105.04TRUE00
2026-03-20248.05CALL0 5100.78TRUE00
2026-03-20255CALL0 389.01TRUE00
2026-03-20265.1CALL5 1591.45TRUE5.10
2026-03-20273.43CALL0 4184.8TRUE00
2026-03-20283.1CALL0 4591.31TRUE00
2026-03-20293.06CALL0 3783.19TRUE00
2026-03-20302.35CALL42 11171.39FALSE-0.15-0.06
2026-03-20312.75CALL2 3275.61FALSE2.750
2026-03-20321.75CALL160 35874.49FALSE0.150.09
2026-03-20331.4CALL0 27760.87FALSE00
2026-03-20341.15CALL1 6865.43FALSE0.050.05
2026-03-20350.91CALL1 34171.3FALSE0.910
2026-03-20360.71CALL0 36372.53FALSE00
2026-03-20370.25CALL0 54075.19FALSE00
2026-03-20380.45CALL0 11571.98FALSE00
2026-03-20390.5CALL0 27101.76FALSE00
2026-03-20400CALL0 0104.99FALSE00
2026-03-20201.16PUT0 780.65FALSE00
2026-03-20210PUT0 076.3FALSE00
2026-03-20220.55PUT0 3077.51FALSE00
2026-03-20230.76PUT0 2117.52FALSE00
2026-03-20240.73PUT0 276.33FALSE00
2026-03-20251.15PUT0 4675.44FALSE00
2026-03-20261.2PUT1 1870.48FALSE-0.27-0.18
2026-03-20271.81PUT0 4071.25FALSE00
2026-03-20282.26PUT0 12075.76FALSE00
2026-03-20292.45PUT0 15468.18FALSE00
2026-03-20303.7PUT0 22767.29TRUE00
2026-03-20313PUT0 462.73TRUE00
2026-03-20324.14PUT0 763.29TRUE00
2026-03-20334.14PUT0 662.31TRUE00
2026-03-20345.29PUT0 159.55TRUE00
2026-03-20357.2PUT0 3158.29TRUE00
2026-03-20366.8PUT0 463.83TRUE00
2026-03-20376.62PUT0 259.66TRUE00
2026-03-20387.52PUT0 261.43TRUE00
2026-03-20390PUT0 065.76TRUE00
2026-03-20400PUT0 00TRUE00
2026-05-15150CALL0 092.02TRUE00
2026-05-15209.2CALL0 32493.63TRUE00
2026-05-152310.26CALL0 34568.27TRUE00
2026-05-15249.2CALL0 15083.16TRUE00
2026-05-15256CALL0 56175.68TRUE00
2026-05-15267.75CALL0 25677.93TRUE00
2026-05-15278CALL0 777.4TRUE00
2026-05-15284.55CALL0 3075.36TRUE00
2026-05-15294.3CALL1 14970.19TRUE4.30
2026-05-15304CALL3 50772.28FALSE40
2026-05-15313.42CALL1 6268.98FALSE3.420
2026-05-15323.05CALL0 16971.65FALSE00
2026-05-15332.51CALL0 11269.02FALSE00
2026-05-15342.6CALL0 7370.15FALSE00
2026-05-15352.34CALL0 32469.05FALSE00
2026-05-15362.05CALL0 4070.17FALSE00
2026-05-15372.35CALL0 1085.06FALSE00
2026-05-15381.37CALL0 3163.79FALSE00
2026-05-15391.6CALL0 6782.06FALSE00
2026-05-15401.16CALL0 33669.36FALSE00
2026-05-15411.45CALL0 3185.37FALSE00
2026-05-15420.94CALL0 2670.22FALSE00
2026-05-15450.7CALL76 103069.55FALSE0.70
2026-05-15500.46CALL0 35570.11FALSE00
2026-05-15550.3CALL10 18374.34FALSE0.30
2026-05-15150.3PUT0 13131.49FALSE00
2026-05-15200.63PUT0 465132.06FALSE00
2026-05-15231.4PUT0 5975.02FALSE00
2026-05-15241.6PUT6 9972.41FALSE1.60
2026-05-15251.8PUT0 6674.97FALSE00
2026-05-15262.25PUT3 16971.11FALSE2.250
2026-05-15272.65PUT1 386765.94FALSE2.650
2026-05-15283.4PUT0 3068.87FALSE00
2026-05-15293.7PUT0 328063.13FALSE00
2026-05-15304.75PUT0 96862.86TRUE00
2026-05-15316.28PUT0 21166.14TRUE00
2026-05-15325.4PUT0 2565.4TRUE00
2026-05-15335.95PUT0 573.51TRUE00
2026-05-15347.1PUT0 264.69TRUE00
2026-05-15357.7PUT0 6965.75TRUE00
2026-05-15368.38PUT0 4262.55TRUE00
2026-05-153710.9PUT0 2064.56TRUE00
2026-05-15380PUT0 064.17TRUE00
2026-05-15399.79PUT0 1663.23TRUE00
2026-05-154011.8PUT0 2664.13TRUE00
2026-05-154112.97PUT0 764.73TRUE00
2026-05-15420PUT0 055.58TRUE00
2026-05-154515.1PUT0 30TRUE00
2026-05-155020.13PUT0 2000TRUE00
2026-05-15550PUT0 00TRUE00
2026-08-21150CALL0 086.38TRUE00
2026-08-212010CALL0 2771.98TRUE00
2026-08-21210CALL0 073.98TRUE00
2026-08-212212.18CALL0 2473.46TRUE00
2026-08-21239.51CALL0 373.29TRUE00
2026-08-21240CALL0 081.53TRUE00
2026-08-21258.4CALL10 4275.93TRUE8.40
2026-08-21268.05CALL0 9873.1TRUE00
2026-08-21276.11CALL0 4369.45TRUE00
2026-08-21287.9CALL0 3577.11TRUE00
2026-08-21297.59CALL0 662.36TRUE00
2026-08-21306CALL3 6873.41FALSE60
2026-08-21317.6CALL0 1069.42FALSE00
2026-08-21325.3CALL0 2168.22FALSE00
2026-08-21336.3CALL0 1667.66FALSE00
2026-08-21344.7CALL0 1168.62FALSE00
2026-08-21353.8CALL2 6966.66FALSE0.050.01
2026-08-21363.1CALL0 164.75FALSE00
2026-08-21372.75CALL0 6461.94FALSE00
2026-08-21380CALL0 064.72FALSE00
2026-08-21392.32CALL0 1275.06FALSE00
2026-08-21402.7CALL10 7867.37FALSE00
2026-08-21451.52CALL0 767.5FALSE00
2026-08-21150.53PUT3 074.12FALSE0.530
2026-08-21202.05PUT0 4670.03FALSE00
2026-08-21210PUT0 066.54FALSE00
2026-08-21222.3PUT0 354.9FALSE00
2026-08-21232.52PUT0 868.97FALSE00
2026-08-21242.45PUT0 1579.14FALSE00
2026-08-21253.1PUT0 468.58FALSE00
2026-08-21263.7PUT0 262.53FALSE00
2026-08-21273.9PUT0 168.89FALSE00
2026-08-21284.1PUT0 5167.83FALSE00
2026-08-21295.63PUT0 466.47FALSE00
2026-08-21305PUT0 1564.82TRUE00
2026-08-21316.83PUT0 064.09TRUE00
2026-08-21320PUT0 064.84TRUE00
2026-08-21337.5PUT0 268.27TRUE00
2026-08-21340PUT0 072.03TRUE00
2026-08-21350PUT0 071.38TRUE00
2026-08-21360PUT0 071.1TRUE00
2026-08-213710.5PUT0 063.22TRUE00
2026-08-21380PUT0 062.36TRUE00
2026-08-21390PUT0 061.2TRUE00
2026-08-21400PUT0 061.1TRUE00
2026-08-21450PUT0 058.5TRUE00
2027-01-151319.3CALL0 18288.82TRUE00
2027-01-151516.17CALL2 80580.6TRUE16.170
2027-01-151814.9CALL0 15378.56TRUE00
2027-01-152012.2CALL0 97266TRUE00
2027-01-152211.4CALL4 449071.66TRUE00
2027-01-15259.65CALL2 78668.63TRUE0.450.05
2027-01-15278.29CALL0 31462.93TRUE00
2027-01-15308.47CALL0 81566.77FALSE00
2027-01-15326CALL0 24967.61FALSE00
2027-01-15355.6CALL0 306957.4FALSE00
2027-01-15375CALL0 23165.28FALSE00
2027-01-15404.4CALL6 131865.27FALSE0.20.05
2027-01-15423.3CALL0 6859.35FALSE00
2027-01-15453.6CALL0 103468.01FALSE00
2027-01-15472.61CALL0 26661.68FALSE00
2027-01-15502.4CALL1 65761.89FALSE0.20.09
2027-01-15551.57CALL0 19058.41FALSE00
2027-01-15601.24CALL0 160556.21FALSE00
2027-01-15130.78PUT0 4478.85FALSE00
2027-01-15151.18PUT0 11569.3FALSE00
2027-01-15182PUT0 8068.69FALSE00
2027-01-15203PUT0 17266.94FALSE00
2027-01-15223.33PUT0 12366.36FALSE00
2027-01-15255PUT0 224364.84FALSE00
2027-01-15276.18PUT0 10964.4FALSE00
2027-01-15307.53PUT0 39365.47TRUE00
2027-01-15328.21PUT0 1861.69TRUE00
2027-01-153510.07PUT10 172261.17TRUE0.040
2027-01-153710.41PUT0 1466.97TRUE00
2027-01-154012.59PUT0 19859.03TRUE00
2027-01-154214.32PUT0 17258.2TRUE00
2027-01-154517.1PUT0 49160.47TRUE00
2027-01-15470PUT0 056.12TRUE00
2027-01-155021.5PUT0 76055.44TRUE00
2027-01-155525.2PUT0 7052.78TRUE00
2027-01-156031PUT1 1555.74TRUE310
2028-01-211516.75CALL0 1663.49TRUE00
2028-01-212014.9CALL0 5270.03TRUE00
2028-01-212314.5CALL0 8266.92TRUE00
2028-01-212512.27CALL0 21364.93TRUE00
2028-01-212811.65CALL0 6366.75TRUE00
2028-01-213010.8CALL0 18366.07FALSE00
2028-01-21329.2CALL0 34462.08FALSE00
2028-01-21357.5CALL0 3661.44FALSE00
2028-01-21377.04CALL0 1261.22FALSE00
2028-01-21406.75CALL0 2460.91FALSE00
2028-01-21420CALL0 058.91FALSE00
2028-01-21456.1CALL0 84461.26FALSE00
2028-01-21504.45CALL0 5561.17FALSE00
2028-01-21554.6CALL19 71660.22FALSE0.730.19
2028-01-21152.37PUT0 375.2FALSE00
2028-01-21203.95PUT0 1363.68FALSE00
2028-01-21234.61PUT0 063.89FALSE00
2028-01-21255.93PUT0 463.26FALSE00
2028-01-21287.76PUT0 261.51FALSE00
2028-01-21309.4PUT0 16857.55TRUE00
2028-01-213211.35PUT0 561.35TRUE00
2028-01-213511.85PUT0 661.13TRUE00
2028-01-213712.27PUT0 358.48TRUE00
2028-01-214013PUT0 1557.22TRUE00
2028-01-21420PUT0 057.07TRUE00
2028-01-214518PUT0 158TRUE00
2028-01-215022.7PUT0 7455.4TRUE00
2028-01-215526.29PUT0 454.31TRUE00

Latest TGTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST987$4.135
Jun 13, 2022 7:59 PM EST93$4.14
Jun 13, 2022 7:59 PM EST1$4.14
Jun 13, 2022 7:59 PM EST10$4.14
Jun 13, 2022 7:59 PM EST200$4.135

TG Therapeutics, Inc (TGTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1001316/000000000018021923/0000000000-18-021923-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375119000238/0000093751-19-000238-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375120000475/0000093751-20-000475-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719006548/0000215457-19-006548-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719008047/0000215457-19-008047-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506618001636/0000315066-18-001636-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506619001380/0000315066-19-001380-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506620001583/0000315066-20-001583-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000083423720008183/0000834237-20-008183-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266419001008/0000902664-19-001008-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266420001111/0000902664-20-001111-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920021910/0001104659-20-021910-index.htm
2020-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920058131/0001104659-20-058131-index.htm
2020-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920072021/0001104659-20-072021-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080593/0001104659-20-080593-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000110465920092406/0001104659-20-092406-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-05-31PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036119010173/0001140361-19-010173-index.htm
2020-05-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036120012674/0001140361-20-012674-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000114420419008306/0001144204-19-008306-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266118000780/0001172661-18-000780-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000823/0001172661-19-000823-index.htm
2019-03-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000927/0001172661-19-000927-index.htm
2020-01-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000001/0001172661-20-000001-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000786/0001172661-20-000786-index.htm
2018-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518195773/0001193125-18-195773-index.htm
2018-07-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518215834/0001193125-18-215834-index.htm
2019-03-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924419000034/0001319244-19-000034-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924420000018/0001319244-20-000018-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000155837020001897/0001558370-20-001897-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020001925/0001558370-20-001925-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020002992/0001558370-20-002992-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020002997/0001558370-20-002997-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004647/0001558370-20-004647-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004651/0001558370-20-004651-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004722/0001558370-20-004722-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020005097/0001558370-20-005097-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006304/0001558370-20-006304-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006314/0001558370-20-006314-index.htm
2020-05-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006630/0001558370-20-006630-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006795/0001558370-20-006795-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006811/0001558370-20-006811-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020007744/0001558370-20-007744-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020010225/0001558370-20-010225-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020012661/0001558370-20-012661-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418001025/0001654954-18-001025-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418002262/0001654954-18-002262-index.htm
2018-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495418002638/0001654954-18-002638-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004295/0001654954-18-004295-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004519/0001654954-18-004519-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004521/0001654954-18-004521-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004821/0001654954-18-004821-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418005046/0001654954-18-005046-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006261/0001654954-18-006261-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006381/0001654954-18-006381-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006609/0001654954-18-006609-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006703/0001654954-18-006703-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006743/0001654954-18-006743-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006777/0001654954-18-006777-index.htm
2018-06-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006935/0001654954-18-006935-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495418007460/0001654954-18-007460-index.htm
2018-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007816/0001654954-18-007816-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418008559/0001654954-18-008559-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418008750/0001654954-18-008750-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418010436/0001654954-18-010436-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418011171/0001654954-18-011171-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418012263/0001654954-18-012263-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418012303/0001654954-18-012303-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418013524/0001654954-18-013524-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000641/0001654954-19-000641-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002047/0001654954-19-002047-index.htm
2019-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002091/0001654954-19-002091-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002189/0001654954-19-002189-index.htm
2019-03-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002274/0001654954-19-002274-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002276/0001654954-19-002276-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419003766/0001654954-19-003766-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005036/0001654954-19-005036-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005037/0001654954-19-005037-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005419/0001654954-19-005419-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005592/0001654954-19-005592-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419005680/0001654954-19-005680-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007297/0001654954-19-007297-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419009109/0001654954-19-009109-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419009176/0001654954-19-009176-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495419010203/0001654954-19-010203-index.htm
2019-09-05RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010400/0001654954-19-010400-index.htm
2019-09-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010402/0001654954-19-010402-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010620/0001654954-19-010620-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012023/0001654954-19-012023-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012611/0001654954-19-012611-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419012751/0001654954-19-012751-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419013703/0001654954-19-013703-index.htm
2019-12-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419014167/0001654954-19-014167-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419014209/0001654954-19-014209-index.htm
2018-07-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1001316/999999999518001856/9999999995-18-001856-index.htm
2018-04-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718005345/9999999997-18-005345-index.htm
2018-09-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718007926/9999999997-18-007926-index.htm

TG Therapeutics, Inc (TGTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TG Therapeutics, Inc (TGTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 713%
Institutional Ownership: 6724%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-17WILLIAM JAMES KENNEDYDirectorBuy27,048.00102,378.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2020-06-22WILLIAM JAMES KENNEDYDirectorBuy15,000.00109,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2018-06-26MICHAEL S WEISSCEO and PresidentBuy1,018,011.0011,648,805.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-26Kenneth HobermanDirectorBuy15,000.00116,905.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-06-26Yann EchelardDirectorBuy15,000.00117,068.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-26Laurence N CharneyDirectorBuy15,000.00118,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2019-09-17DANIEL HUMEDirectorBuy27,048.00119,507.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2018-06-26MARK SCHOENEBAUMDirectorBuy15,000.00125,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2020-09-09RA CAPITAL MANAGEMENT, L.P.10% Share HolderSell158,589.0025.814,092,738.0412,629,868.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-06-13MICHAEL S WEISSCEO and PresidentBuy1,179,380.0012,828,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-26MICHAEL S WEISSCEO and PresidentBuy50,000.007.04351,750.0012,878,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2020-06-22DANIEL HUMEDirectorBuy15,000.00134,507.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2019-09-17Kenneth HobermanDirectorBuy27,048.00143,953.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-09-17Yann EchelardDirectorBuy27,048.00144,116.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2020-06-22MICHAEL S WEISSCEO and PresidentBuy1,556,029.0014,434,214.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2019-09-17Laurence N CharneyDirectorBuy27,048.00145,997.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2020-06-22Kenneth HobermanDirectorBuy15,000.00158,953.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-22Yann EchelardDirectorBuy15,000.00159,116.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-22Laurence N CharneyDirectorBuy15,000.00160,997.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2019-07-01Sean A PowerCFO, Secretary and TreasurerSell17,654.008.47149,529.38383,338.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-01-02Sean A PowerCFO, Secretary and TreasurerSell37,275.004.13153,945.75400,992.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy50,000.00433,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2018-07-03Sean A PowerCFO, Secretary and TreasurerSell35,000.0013.19461,650.00438,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-02Sean A PowerCFO, Secretary and TreasurerSell12,191.0013.26161,652.66473,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-06-14WILLIAM JAMES KENNEDYDirectorSell25,071.0013.45337,204.9560,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy200,000.00633,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-06-22Sagar LonialDirectorBuy65,000.0065,000.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-06-26WILLIAM JAMES KENNEDYDirectorBuy15,000.0075,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-26DANIEL HUMEDirectorBuy15,000.0092,459.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2020-06-17WILLIAM JAMES KENNEDYDirectorSell7,745.0018.27141,501.1594,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm